Edition:
United States

Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.17USD
1:07pm EST
Change (% chg)

$-0.03 (-2.50%)
Prev Close
$1.20
Open
$1.20
Day's High
$1.24
Day's Low
$1.17
Volume
14,025
Avg. Vol
30,809
52-wk High
$5.69
52-wk Low
$1.16

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 18.90 -1.349
Jun '17 23.36 -2.003
Mar '17 19.15 -4.666
FY 2016 Dec '16 13.88 -1.686
Sep '16 7.00 1.302
Jun '16 7.79 -1.732
Mar '16 5.03 -1.535
FY 2015 Dec '15 4.93 -1.223
Sep '15 9.97 -0.859
Jun '15 5.19 -1.798
Mar '15 4.36 -1.391
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 25.00 25.00 25.00 15.30
Quarter Ending Mar-18 1 27.50 27.50 27.50 --
Year Ending Dec-17 2 85.85 87.00 84.70 69.49
Year Ending Dec-18 2 133.25 156.50 110.00 --
Earnings (per share)
Quarter Ending Dec-17 1 -2.06 -2.06 -2.06 --
Quarter Ending Mar-18 1 -2.17 -2.17 -2.17 --
Year Ending Dec-17 2 -8.60 -7.13 -10.08 -5.02
Year Ending Dec-18 2 -5.15 -3.54 -6.76 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 2.37 0.82 0.91
Price to Sales (TTM) 0.25 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 45.54 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 169.97 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 204.09 29.98 5.62
Sales - 5 Yr. Growth Rate 50.27 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -203.63 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -204.34 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.71 1.79 2.55
Current Ratio (MRQ) 2.00 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.66 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -198.74 -- --
EBITD - 5 Yr. Avg -255.08 -215.66 15.63
Operating Margin (TTM) -173.92 -642.63 6.56
Operating Margin - 5 Yr. Avg. -246.13 -232.87 11.00
Pre-Tax Margin (TTM) -192.48 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -246.37 -233.04 11.41
Net Profit Margin (TTM) -192.65 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -247.63 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 570,356 22,314,532 851,801,741
Net Income/Employee (TTM) -1,098,811 -1,997,855 99,542,701
Receivable Turnover (TTM) 7.10 26.15 6.13
Inventory Turnover (TTM) 1.06 2.62 3.56
Asset Turnover (TTM) 0.28 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.76 -9.39 11.31
Return on Assets - 5 Yr. Avg. -29.98 0.28 12.28
Return on Investment (TTM) -69.42 -11.76 14.43
Return on Investment - 5 Yr. Avg. -35.15 3.42 16.07
Return on Equity (TTM) -2,625.21 -36.72 16.01
Return on Equity - 5 Yr. Avg. -118.72 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 37.82 114.24 50.27
EPS (TTM) % 67.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Orexigen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -28.99 -31.57 6 94
13 Week -47.83 -51.25 6 75
26 Week -56.99 -60.89 7 59
52 Week -36.51 -46.33 21 58
YTD -31.03 -42.30 26 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.54%
# of Holders: 59
Total Shares Held: 7,027,335
3 Mo. Net Change: -379,965
# New Positions: 5
# Closed Positions: 13
# Increased Positions: 17
# Reduced Positions: 22
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.